MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma

被引:7
|
作者
Ji, L. [1 ,2 ]
Zhu, Z-N [2 ,3 ]
He, C-J [4 ]
Shen, X. [5 ]
机构
[1] Nanchang Univ, Affiliated Stomatol Hosp, Dept Gen Dent, Nanchang, Jiangxi, Peoples R China
[2] Key Lab Oral Biomed, Nanchang, Jiangxi, Peoples R China
[3] Nanchang Univ, Affiliated Stomatol Hosp, Dept Oral & Maxillofacial Surg, Nanchang, Jiangxi, Peoples R China
[4] Nanchang Univ, Fuzhou Med Coll, Fuzhou, Fujian, Peoples R China
[5] Nantong Univ, Dept Stomatol, Affiliated Hosp, Nantong, Peoples R China
关键词
miR-127-3p; Proliferation; Metastasis; Prognosis; KIF3B; Oral squamous cell carcinoma; TUMOR-SUPPRESSOR; DOWN-REGULATION; CANCER; PROLIFERATION; METASTASIS; STATISTICS; MIGRATION; INVASION; GROWTH; INJURY;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: Recently, increased microRNAs have been shown to play an important role in the pathogenesis and progression of human cancers. including oral squamous cell carcinoma (OSCC). In this study, we focused on the function of microRNA-127-3p (miR-127-3p) associated with OSCC carcinogenesis. PATIENTS AND METHODS: MiR-127-3p and KIF3B expressions were observed via quantitative Real-time polymerase chain reaction (qRT-PCR) or Western blot in OSCC. The functions of mR-127-3p and KIF3B were investigated through MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) and transwell assays. And luciferase reporter assay was performed to confirm the relationship between mR-127-3p and KIF3B. RESULTS: First, down-regulation of miR-127-3p was identified in OSCC, which was associated with malignant clinicopathological features and poor prognosis in OSCC patients. Functionally, overexpression of miR-127-3p led to inhibition of cell proliferation and metastasis in OSCC. Further, KIF3B was confirmed to be a direct target of miR-127-3p. Moreover, upregulation of KIF3B was also observed in OSCC, which promoted tumorigenesis of OSCC. In particular, the upregulation of KIF3B partially attenuated the inhibitory effect of miR-127-3p on the development of OSCC. CONCLUSIONS: MiR-127-3p targeted KIF3B to inhibit the development of OSCC through suppressing cell proliferation, migration and invasion.
引用
收藏
页码:630 / 640
页数:11
相关论文
共 50 条
  • [1] miR-127-3p通过靶向KIF3B抑制卵巢癌细胞增殖、侵袭及迁移
    郑小妹
    林叶飞
    陈曼玲
    现代肿瘤医学, 2022, 30 (19) : 3476 - 3481
  • [2] miR-127-3p靶向KIF3B缓解卵巢癌对紫杉醇的耐药性
    王佳
    李瑞
    张菲菲
    梁葵香
    沈阳药科大学学报, 2023, 40 (09) : 1187 - 1192+1199
  • [3] Suppression of miR-127-3p prevents cardiac fibrosis
    Zhou, Q.
    Liu, Z.
    Bei, Y.
    Zhang, Z.
    Zhou, L.
    Xiao, J.
    EUROPEAN HEART JOURNAL, 2018, 39 : 993 - 993
  • [4] MicroRNA-127 inhibits cell proliferation via targeting Kif3b in pancreatic β cells
    Shen, Ziyang
    Jiang, Hemin
    Hsu, Hsiang-Ting
    Qian, Li
    Fu, Qi
    Shen, Min
    Chen, Shu
    Yang, Tao
    AGING-US, 2019, 11 (05): : 1342 - 1355
  • [5] Tumor Suppressor Function of miR-127-3p and miR-376a-3p in Osteosarcoma Cells
    Fellenberg, Joerg
    Lehner, Burkhard
    Saehr, Heiner
    Schenker, Astrid
    Kunz, Pierre
    CANCERS, 2019, 11 (12)
  • [6] A novel role of KIF3b in the seminoma cell cycle
    Shen, Hao-Qing
    Xiao, Yu-Xi
    She, Zhen-Yu
    Tan, Fu-Qing
    Yang, Wan-Xi
    EXPERIMENTAL CELL RESEARCH, 2017, 352 (01) : 95 - 103
  • [7] Plasma miR-200b-3p level for oral squamous cell carcinoma diagnosis
    Zhang, Guo-Ming
    BIOMARKERS, 2017, 22 (07) : 700 - 700
  • [8] MiR-101-3p targets KPNA2 to inhibit the progression of lung squamous cell carcinoma cell lines
    Dong, Liangliang
    Jiang, Hanliang
    Qiu, Ting
    Xu, Yiming
    Chen, Enguo
    Huang, Aihua
    Ying, Kejing
    HISTOLOGY AND HISTOPATHOLOGY, 2023, 38 (10) : 1169 - 1178
  • [9] miR-30a-5p targets ITGA6 to inhibit oral squamous cell carcinoma progression
    Zhang, Guodong
    Wang, Haiqin
    Liu, Gui
    Huang, Junhui
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 253
  • [10] Intronic miR-6741-3p targets the oncogene SRSF3: Implications for oral squamous cell carcinoma pathogenesis
    More, Dhanashree Anil
    Singh, Nivedita
    Mishra, Radha
    Muralidharan, Harsha Pulakkat
    Gopinath, Kodaganur Srinivas
    Gopal, Champaka
    Kumar, Arun
    PLOS ONE, 2024, 19 (05):